Latest Deals
Credit: sfam_photo/Shutterstock.com
THL signs $2.5bn takeover deal for US healthtech company Agiliti
US private equity company Thomas H Lee Partners (THL), has signed a definitive agreement to acquire medical technology management and service solutions provider Agiliti, valuing the business at approximately $2.5bn. Upon completion of the deal, Agiliti will become a private company and no longer be publicly listed or traded on the NYSE. As part of the latest deal, THL will purchase all outstanding shares of Agiliti common stock that are currently not owned by THL, its affiliates, and management shareholders, for $10.00 each in cash.
Bruker signs agreement to acquire ELITechGroup for $942m
Life sciences and diagnostics company Bruker has agreed to acquire ELITechGroup, a provider of in-vitro diagnostic (IVD) systems, in a €870m ($942m) cash deal. ELITechGroup will be acquired from TecFin, a controlled affiliate of pre-eminent private equity company PAI Partners. However, the transaction excludes ELITech’s clinical chemistry business, which is being carved out. Earlier, Bruker signed a put option agreement with PAI Partners, pending workers’ council consultations in France and the Netherlands. The option, which has now been exercised, places the parties into a binding share purchase agreement.
Aptar acquires digital health company Healint
Aptar Digital Health has announced the acquisition of Healint, a Singapore-based company known for its virtual clinical studies and patient support applications. The acquisition forms part of Aptar Digital Health’s efforts to expand its portfolio in the neurology sector and bolster its global digital health deployment capabilities. Financial terms of the deal were undisclosed.
Investors inject $60m in AI patient management start up Fabric
US-based health tech start-up Fabric has received $60m from investors to kick start its automated, artificial intelligence (AI) driven software which is designed to automate clinical and administrative work in healthcare facilities. The New York-based company said the funds will be used to advance its electronic patient care and management software, known as the In-Person Care Suite, Virtual Care Suite, and Engagement Suite.